126 related articles for article (PubMed ID: 2958286)
1. Actions of a progestogen on human breast cancer cells: mechanisms of growth stimulation and inhibition.
Braunsberg H; Coldham NG; Leake RE; Cowan SK; Wong W
Eur J Cancer Clin Oncol; 1987 May; 23(5):563-71. PubMed ID: 2958286
[TBL] [Abstract][Full Text] [Related]
2. Androgen and glucocorticoid receptor-mediated inhibition of cell proliferation by medroxyprogesterone acetate in ZR-75-1 human breast cancer cells.
Poulin R; Baker D; Poirier D; Labrie F
Breast Cancer Res Treat; 1989 Mar; 13(2):161-72. PubMed ID: 2525057
[TBL] [Abstract][Full Text] [Related]
3. Hormone and cytotoxic drug responsiveness of cultured human breast cancer cells resistant to specific hormones.
Coldham NG; Patel K; Braunsberg H
Int J Cancer; 1990 Apr; 45(4):712-8. PubMed ID: 2139015
[TBL] [Abstract][Full Text] [Related]
4. Effect of medroxyprogesterone acetate on proliferation and cell cycle kinetics of human mammary carcinoma cells.
Sutherland RL; Hall RE; Pang GY; Musgrove EA; Clarke CL
Cancer Res; 1988 Sep; 48(18):5084-91. PubMed ID: 2970295
[TBL] [Abstract][Full Text] [Related]
5. Dexamethasone and medroxyprogesterone acetate elevate Nm23-H1 metastasis suppressor gene expression in metastatic human breast carcinoma cells: new uses for old compounds.
Ouatas T; Halverson D; Steeg PS
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3763-72. PubMed ID: 14506169
[TBL] [Abstract][Full Text] [Related]
6. Histidine potentiates the antiproliferative effect of medroxyprogesterone acetate (MPA) on a human breast cancer cell line.
Giubertoni M; Badino P; Conti G; Racca S; Di Carlo F
Pharmacol Res; 1990; 22 Suppl 3():9-10. PubMed ID: 2151472
[No Abstract] [Full Text] [Related]
7. [Effects of antiestrogens and medroxyprogesterone acetate on the clonogenic growth of tamoxifen-sensitive and resistant human breast cancer cells].
Nomura Y; Tashiro H; Takaeko F
Gan To Kagaku Ryoho; 1985 Apr; 12(4):844-50. PubMed ID: 3157351
[TBL] [Abstract][Full Text] [Related]
8. Antiproliferative effect of leuprorelin acetate, alone or combined with tamoxifen or medroxyprogesterone acetate, on human breast cancer cell lines.
Sica G; Iacopino F; Marini L; Robustelli della Cuna G
Clin Ther; 1992; 14 Suppl A():87-96. PubMed ID: 1535023
[TBL] [Abstract][Full Text] [Related]
9. [Effects of estrogen and endocrine therapeutic agents on the estrogen receptor, progesterone receptor and DNA synthesis in MCF-7 human breast cancer cells using the whole cell uptake method].
Kurebayashi J; Horiuchi R; Nakamura T; Iino Y; Ishida T; Takigawa H; Izuo M
Nihon Naibunpi Gakkai Zasshi; 1987 Nov; 63(11):1351-63. PubMed ID: 2965035
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms involved in the evolution of progestin resistance in human breast cancer cells.
Murphy LC; Dotzlaw H; Wong MS; Miller T; Murphy LJ
Cancer Res; 1991 Apr; 51(8):2051-7. PubMed ID: 1849041
[TBL] [Abstract][Full Text] [Related]
11. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
van den Berg HW; Martin J; Lynch M
Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575
[TBL] [Abstract][Full Text] [Related]
12. Adriamycin action on human breast cancer cells: enhancement by medroxyprogesterone acetate.
Shaikh NA; Owen AM; Ghilchik MW; Braunsberg H
Int J Cancer; 1989 Apr; 43(4):733-6. PubMed ID: 2522913
[TBL] [Abstract][Full Text] [Related]
13. Growth stimulation and differential regulation of transforming growth factor-beta 1 (TGF beta 1), TGF beta 2, and TGF beta 3 messenger RNA levels by norethindrone in MCF-7 human breast cancer cells.
Jeng MH; Jordan VC
Mol Endocrinol; 1991 Aug; 5(8):1120-8. PubMed ID: 1834933
[TBL] [Abstract][Full Text] [Related]
14. Hormonal therapies for breast cancer: can progestogens stimulate growth?
Braunsberg HA; Coldham NG; Wong W
Cancer Lett; 1986 Feb; 30(2):213-8. PubMed ID: 2937532
[TBL] [Abstract][Full Text] [Related]
15. The effect of oestrogens and medroxyprogesterone acetate on the uptake of cytotoxic drugs by MCF-7 breast cancer cells.
Reed MJ; Ross MS; Ghilchik MW
Anticancer Res; 1992; 12(2):533-6. PubMed ID: 1533753
[TBL] [Abstract][Full Text] [Related]
16. Medroxyprogesterone acetate inhibits the proliferation of estrogen- and progesterone-receptor negative MFM-223 human mammary cancer cells via the androgen receptor.
Hackenberg R; Hawighorst T; Filmer A; Nia AH; Schulz KD
Breast Cancer Res Treat; 1993; 25(3):217-24. PubMed ID: 8369523
[TBL] [Abstract][Full Text] [Related]
17. Medroxyprogesterone acetate: receptor binding and correlated effects on steroidogenesis in rat granulosa cells.
Pridjian G; Schmit V; Schreiber J
J Steroid Biochem; 1987 Mar; 26(3):313-9. PubMed ID: 2953940
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of continuous combined and sequential combined medroxyprogesterone acetate-estradiol treatment on the proliferation of MCF-7 cells.
Lippert C; Seeger H; Wallwiener D; Mueck AO
Climacteric; 2000 Dec; 3(4):271-7. PubMed ID: 11910587
[TBL] [Abstract][Full Text] [Related]
19. The effect of medroxyprogesterone acetate on aromatase and DNA polymerase alpha activities in breast tumours.
Purohit A; Lai LC; Singh A; Coldham NG; Ghilchik MW; Reed MJ; James VH
J Steroid Biochem; 1989; 34(1-6):443-6. PubMed ID: 2533950
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the proliferative effects of estradiol and conjugated equine estrogens on human breast cancer cells and impact of continuous combined progestogen addition.
Mueck AO; Seeger H; Wallwiener D
Climacteric; 2003 Sep; 6(3):221-7. PubMed ID: 14567770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
